General Information
Revision date
2026-02-17
Product name
AC PATINIERTINKTUR 4601-00 - All variants
1.2.1 Relevant identified uses
Paint
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H317, H319, H336, H412
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapour. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness. H412 - Harmful to aquatic life with long lasting effects.
Prevention
P280 - Wear protective gloves. Wear eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P273 - Avoid release to the environment.
Response
P304 + P312 - IF INHALED: Call a POISON CENTER or doctor if you feel unwell.
Storage
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
1-Methoxy 2-propanol; Butanone and Amines, C12-14-tert-alkyl, bis[2-[ (4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 2, H225 Eye Irrit. 2, H319 Skin Sens. 1, H317 STOT SE 3, H336 Aquatic Chronic 3, H412 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.